Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
3.050
+0.190 (6.64%)
Aug 4, 2026, 2:06 PM EDT - Market open
Elicio Therapeutics Employees
Elicio Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
n/a
Profits / Employee
-$1,217,727
Market Cap
71.53M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | 1 | 3.13% |
| Dec 31, 2024 | 32 | 0 | - |
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Pliant Therapeutics | 49 |
| Spero Therapeutics | 25 |
| LeonaBio | 19 |
| ImageneBio | 17 |
| Cingulate | 14 |
ELTX News
- 4 weeks ago - Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering - GlobeNewsWire
- 4 weeks ago - Elicio Therapeutics announces pricing of $15M registered direct offering - TheFly
- 4 weeks ago - Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - GlobeNewsWire
- 5 weeks ago - Elicio Therapeutics joins Russell 2000, Russell 3000 Indexes - TheFly
- 5 weeks ago - Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 5 weeks ago - Elicio Therapeutics Transcript: KOL event - Transcripts
- 5 weeks ago - Elicio Therapeutics Slides: KOL event - Filings
- 5 weeks ago - Elicio Therapeutics Slides: Corporate presentation - Filings